Document Detail


Intravitreal bevacizumab versus low-fluence photodynamic therapy for treatment of chronic central serous chorioretinopathy.
MedLine Citation:
PMID:  22915299     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To report the effectiveness and safety of intravitreal bevacizumab injection (IVB) compared with low-fluence photodynamic therapy (L-PDT) in eyes with chronic central serous chorioretinopathy (CSC).
METHODS: This was a prospective comparative interventional study of 22 patients affected by chronic CSC. Patients were randomly assigned to group 1 (12 patients treated with 1.25 mg IVB) and group 2 (10 patients treated with L-PDT). In group 2, PDT with verteporfin was delivered at low fluence (300 mW/cm(2) for 83 s, 25 J/cm(2)). Follow-up visits were scheduled at 1, 3, 6, and 9 months.
RESULTS: The improvement in visual acuity was greater in group 1 than in group 2, although the difference was not statistically significant (P = 0.59). The mean change in central point thickness over 9 months from baseline was 127 μm (SD 36) in group 1 and 114 μm (SD 42) in group 2. After the first injection, retreatments were given if recurrence was noted, with an average of 3.0 ± 1 injections in group 1 and 1.6 ± 0.6 treatments with L-PDT in group 2. The difference between retreatment in the 2 groups was not statistically significant (P = 0.45).
CONCLUSIONS: Based on the results obtained after 9 months of follow-up, our study provides evidence that IVB may be a treatment option for chronic CSC.
Authors:
Francesco Semeraro; Mario R Romano; Paola Danzi; Francesco Morescalchi; Ciro Costagliola
Related Documents :
20696609 - Changing demography of leprosy: kuwait needs to be vigilant.
22675619 - The microcirculation is unchanged in neonates with severe respiratory failure after the...
22895929 - Compression for preventing recurrence of venous ulcers.
15875929 - Predictors of relapse among pulmonary tuberculosis patients treated in a dots programme...
8287749 - Intermittent therapy with high-dose 5-aminosalicylic acid enemas maintains remission in...
22689249 - Lightweight versus heavyweight in inguinal hernia repair: a meta-analysis.
10534249 - Bilateral thalamic stimulation for the treatment of essential tremor.
17016219 - The treatment of pelvic discontinuity with acetabular cages.
20008309 - The first anniversary: stress, well-being, and optimism in older widows.
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial     Date:  2012-08-23
Journal Detail:
Title:  Japanese journal of ophthalmology     Volume:  56     ISSN:  1613-2246     ISO Abbreviation:  Jpn. J. Ophthalmol.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-15     Completed Date:  2013-02-01     Revised Date:  2013-05-27    
Medline Journal Info:
Nlm Unique ID:  0044652     Medline TA:  Jpn J Ophthalmol     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  608-12     Citation Subset:  IM    
Affiliation:
Department of Ophthalmology, University of Brescia, Brescia, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Angiogenesis Inhibitors / administration & dosage*
Antibodies, Monoclonal, Humanized / administration & dosage*
Central Serous Chorioretinopathy / drug therapy*,  physiopathology
Chronic Disease
Female
Fluorescein Angiography
Follow-Up Studies
Humans
Intravitreal Injections
Male
Photochemotherapy*
Prospective Studies
Retina / physiopathology
Tomography, Optical Coherence
Treatment Outcome
Vascular Endothelial Growth Factor A / antagonists & inhibitors
Visual Acuity / physiology
Chemical
Reg. No./Substance:
0/Angiogenesis Inhibitors; 0/Antibodies, Monoclonal, Humanized; 0/VEGFA protein, human; 0/Vascular Endothelial Growth Factor A; 2S9ZZM9Q9V/bevacizumab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Vitamin B-12 Supplementation of Rural Mexican Women Changes Biochemical Vitamin B-12 Status Indicato...
Next Document:  Isolated Pd Sites on the Intermetallic PdGa(111) and PdGa($\bar 1$$\bar 1$$\bar 1$) Model Catalyst S...